Bios Partners overview
Stories about Bios Partners
Trefoil reels in $28 mln
San Diego-based Trefoil Therapeutics, a biotech firm, has secured $28 million in financing. Bios Partners led the round with participation from other investors that included Access Biotechnology, Hatteras Venture Partners, Aju IB Investment, Correlation Ventures, ExSight Ventures and InFocus Capital Partners.
Azitra pockets $2.15 mln
Farmington, Connecticut-based Azitra Inc, a biotech company focused on harnessing the microbiome to treat skin disease, has raised $2.15 million in financing. Connecticut Innovations and Bios Partners were the lead investors. Also, KdT Ventures participated in the round.
Bios Partners targets $50 mln second fund
Bios Partners in Fort Worth, Texas, has filed to raise a $50 million second fund, according to a regulatory filing https://www.sec.gov/Archives/edgar/data/1728851/000172885118000001/xslFormDX01/primary_doc.xml The filing for Bios Fund II NT lists Leslie Kries, Jr. and Aaron Fletcher as managing partners.
VC-backed Azitra taps Andrews as president and CEO
Azitra, which is backed by Bios Partners and Breakout Labs, has named Richard Andrews as president and CEO. Previously, Andrews was CEO of Thrasos Therapeutics. Based in Farmington, Connecticut, Azitra is a focused on treating skin disease via microbiome.
Lung Therapeutics gathers $14.3 mln Series B
Austin, Texas-based Lung Therapeutics Inc, a clinical stage pharmaceutical company, has closed $14.3 million in Series B financing. Bios Partners led the round with participation from return backer, the UT Horizon Fund.
410 Medical nets $3.3 mln Series A
Durham, North Carolina-based 410 Medical Inc, a medical device company focused on developing technologies for critically ill patients, has raised $3.3 million in Series A funding. Bios Partners led the round.
Bios Partners contact information
Offices
1751 River Run, Ste 400, Fort Worth, 76107, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Aaron G. L. Fletcher | Job titleManaging Partner, Managing Director and Co-Founder | LocationFort Worth, United States | Email  ------ |
| Key ContactMr. Troy Osborn | Job titleChief Financial Officer, Investor Relations | LocationFort Worth, United States | Email ------- |
| Mr. Leslie W. Kreis Jr. | Job titleManaging Partner and Co-Founder | LocationFort Worth, United States | Email --------- |
| Dr. Stella M. Robertson | Job titleCo-Founder and Partner | LocationFort Worth, United States | Email --------- |
Bios Partners funds managed
Funds in market: 1
| Fund | Fund size | Open date | Strategy |
|---|---|---|---|
Fund size --------- | Open dateJul 2023 | Strategy ------- | |
Stories that mention Bios Partners
Azitra fetches $14 mln Series A
Farmington, Connecticut-based Azitra Inc, a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, has raised $14 million in Series A financing. KdT Ventures and Bios Partners led the round with participation from Connecticut Innovations and Godfrey Capital.
Actuate Therapeutics inks $21.7 mln Series B
Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.
Actuate Therapeutics inks $21.7 mln Series B
Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.
Lantern Pharma rallies $3.7 mln Series A
Lantern Pharma Inc, a clinical-stage biotech company, has raised $3.7 million in Series A financing. The investors included Bios Partners and GPG Ventures.